Advisors Approve $50 Million NCI Effort To Attack Cancer On a Molecular Level
In Brief: NCCN, ACS Write Prostate Cancer Guideline For Patient use; Gates gives $4.5M to UPCC
NCI Programs: BSA Approves Formation Of Two Grant Programs:
Molecular target Drug Discovery Grants; Unanimously Approved
Centers Of Excellence In Interventions Aimed at molecular Targets; Approved On 19-6 Vote
DO RFAs cut Into R01 Grant Pool? Board Asks
Trending Stories
- Long-awaited results from first phase III trial of a RAS inhibitor in pancreatic cancer shows that daraxonrasib doubles median OS
PanCAN’s Berkenblit: “It’s here. This is a tipping point, and we’ve tipped. And this is just the beginning.” - Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Cancer Center at Illinois is recognized as NCI Basic Cancer Center, becoming the first new institution to earn this designation in 40 years
- NCI Director Letai wants you to know: Grant money is flowing again post-government shutdown
- Most Favored Nation drug pricing could put China on top
- Protecting the cure: Why the future of radiation oncology must be precision-guided









